Sinovac's Stock Exchange Listing Moves to NASDAQ Global Select Market
BEIJING, Dec. 31, 2010 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today its common shares will be listed on the NASDAQ Global Select Market effective January 3, 2011. The Company received notification from the NASDAQ ...
Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
BEIJING, Dec. 28, 2010 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that it received approval from the China State Food and Drug Administration (SFDA) to commence clinical trials for its proprietary inactivated EV...
Sinovac Reports Unaudited Third Quarter 2010 Financial Results
- Conference call scheduled for Monday, November 15, 2010 at 8:00 AM EST - BEIJING, Nov. 15, 2010 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the three-month and nine-month pe...
Sinovac to Host Conference Call to Report Third Quarter 2010 Unaudited Financial Results
BEIJING, Nov. 1, 2010 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it will release its unaudited financial results for the third quarter ended September 30, 2010 before the open of the market on Monday, Novem...
Sinovac Participates in Two Investor Conferences in November
BEIJING, Oct. 27 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that Mr. Jacob Ho, Acting Chief Financial Officer, Ms. Vanessa Wu, Senior Financial Manager and Ms. Helen Yang, Investor Relations Manager, are schedul...
Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
BEIJING, Oct. 25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention (Beijing CDC) as one of the five manufacturers to supply seasonal i...
Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations
BEIJING, Oct. 24 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its preliminary unaudited sales range for the third quarter ended September 30, 2010 and revised sales guidance for full year 2010. A conference call t...
Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)
BEIJING, Oct 24 /PRNewswire-Asia-FirstCall/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that Sinovac Biotech (Hong Kong) Ltd., its wholly owned subsidiary company in Hong Kong, has received the Certificate of Drug/Product Registra...
Sinovac Participates in Three Investor Conferences in September 2010
BEIJING, Sept. 7 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today that Mr. Weidong YIN, Chairman, President & CEO, Mr. Jacob Chik Keung HO, Acting CFO and Ms. Xiaohong WU, Senior Financial Manager, are scheduled to participate...
Sinovac Reports Unaudited Second Quarter 2010 Financial Results
- Conference call scheduled for Monday, August 16, 2010 at 8:00 AM EDT - BEIJING, Aug. 16 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today its unaudited financial results for the three-month and six-month periods ended June 3...
Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results
BEIJING, Aug. 5 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines in China, announced today that it will release its financial results for the second quarter ended June 30, 2010 before the open of the market on Monday, August 16, 2010. The Comp...
Sinovac Holds 2010 Annual Meeting of Shareholders
BEIJING, July 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines in China, announced today that it held its 2010 Annual Meeting of Shareholders on Thursday, July 15, 2010 at 9:00 a.m. Beijing Time. The required quorum, a majority of the comm...
Sinovac Schedules 2010 Annual Meeting of Shareholders
BEIJING, June 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines in China, announced today that it will hold its 2010 Annual Meeting of Shareholders on Thursday, July 15, 2010 at 9:00 a.m. Beijing Time. The meeting will be held concurrently a...
Sinovac Selected by Beijing CDC to Supply Hepatitis A Vaccine Healive(R)
BEIJING, June 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today that it has received the confirmation from the China International Tendering Company that Sinovac was selected by the Beijing Centers for Diseases Control and Prev...
Sinovac to Participate at 2010 Shanghai CPhI Exhibition
BEIJING, May 26 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today that the Company will participate at the 2010 Shanghai CPhI Exhibition, being held June 2-4, 2010. Sinovac's exhibition booth will be located in Hall E4, No. E4C42...
Sinovac to Present at 2010 UBS Global Specialty Pharmaceuticals Conference
BEIJING, May 24 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today that Mr. Weidong Yin, Chairman, President & CEO, will present at the 2010 UBS Global Specialty Pharmaceuticals Conference, which is being held June 2-3, 2010 in Lo...
Sinovac Reports Unaudited First Quarter 2010 Financial Results
Conference call scheduled for Thursday, May 13, 2010 at 8:00 PM EDT BEIJING, May 14 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today its unaudited financial results for the three-month period ended March 31, 2010. Fi...
Sinovac to Host Conference Call to Report First Quarter 2010 Financial Results
BEIJING, May 6 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of vaccines in China, today announced that it will release its financial results for the first quarter ended March 31, 2010 after the close of the market on Thursday, May 13, 2010. The Company will host a ...
Sinovac Submits Clinical Trial Application for Mumps Vaccine to SFDA
- First Live Attenuated Vaccine to be Submitted by Sinovac to SFDA for Clinical Trials - - First Vaccine from Sinovac Dalian's Development Pipeline Accepted by SFDA Following Joint Venture's Formation in January 2010 - BEIJING, May 5 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasd...
Sinovac Filed Its Annual Report on Form 20-F for 2009
BEIJING, April 16 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today it filed its annual report on Form 20-F for the fiscal year ended December 31, 2009 with the Securities and Exchange Commission on April 16, 2010. The annual...
